NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm, P.A. announces that it is investigating potential civil securities claims against Marrone Bio Innovations, Inc. (NASDAQ:MBII) resulting from allegations that the Company issued materially false financial statements to investors.
On September 3, 2014 Marrone shocked the market when it announced that its Audit Committee has commenced an internal investigation concerning revenue recognition in the fourth quarter of 2013. The Company also stated that its financial statements for fiscal year 2013, and the first two quarters of 2014, should no longer be relied upon by investors. In intraday trading on September 3, 2014, this adverse news caused Marrone’s stock to fall more than 40%.
The Rosen Law Firm is preparing a securities class action lawsuit on behalf of Marrone investors. If you would like to recover your losses, please visit the website at http://rosenlegal.com/cases-345.html to join the class action. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org or email@example.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.